跳至主要内容
临床试验/CTRI/2010/091/000562
CTRI/2010/091/000562已完成3 期

Evaluation of efficacy and safety of two antipsychotic agents for the acute treatment of schizophrenia in adults: a randomized, open label, active controlled, multicentric study.

Sun Pharmaceutical Industries Ltd.0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male or female patients aged between 18 and 65 years.
  • 2. Has a primary diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders IV Text Revision (DSM-IV TR).
  • 3. Patient or his/her care taker willing to give their informed consent.

排除标准

  • 1. Pregnant, lactating women or women of childbearing age who are not using an acceptable method of birth control.
  • 2. Patients having hypersensitivity to investigational products or any of the excipients of this formulation.
  • 3. Patients taking drugs that are known to prolong QTc interval.
  • 4. Patients with a history of cardiac arrhythmias.
  • 5. Patients having severe renal and hepatic impairment.
  • 6. Patients who displayed marked suicidal intent or known suicidal tendencies.
  • 7. Alcohol abused patients.

研究者

相似试验